vocxi health greg peterson
Meet

Greg Peterson

EDUCATION/CERTIFICATIONS
Bachelor of Mechanical Engineering, University of Minnesota // Master of Business Administration, University of St. Thomas
SELECTED EXPERIENCE
Advanced Manufacturing Research Engineer, IBM // Military Veteran – US Army // Sales Applications and Business Manager, Sheldahl // Middle US Territory Manager, Kollmorgen, Multiwire // Division VP, President ELCHEM, Inc., Ecolab // Acquisition Liaison Consultant, El DuPont // Co-founder, CEO/President, Board Member, Spinal Designs // Innovation Fellows Volunteer Mentor, University of Minnesota Medical Devices Center // Innovation Collaborations Director, University of Minnesota Medical Devices Center
ASSOCIATIONS/VOLUNTEERING
Advisory Board Member, University of Minnesota Medical Devices Center

For nearly ten years, while working at the University of Minnesota Medical Devices Center, Greg led the collaboration team on the development of what would eventually become the MyBreathPrint® system. Today, as Vocxi Health’s Senior Programs Director, Greg is responsible for building relationships with clinical partners and management oversight of all clinical studies. Greg thrives within the professional energy and respectful comradery of the Vocxi team and enjoys the fast pace of Vocxi’s developing business opportunities. As an accomplished entrepreneur and intrapreneur with more than 40 years of industry experience, Greg has worked in nearly every role of launching a new business or new business lines within a larger company. He is most proud of the contributions he’s made — and is continuing to make — to improving healthcare patient outcomes through invention, innovation, public-private partnership development, and company formation and management.

Patents: 13

spacer

My Why

line right in
“I am a prostate cancer survivor. I experienced nearly 13 months of monitoring before a cancer diagnosis was determined. Traditional biopsy sites missed the cancer and were inconclusive until a biopsy in a non-traditional transistion zone confirmed cancer and at that stage, I had to have surgery. I am now cancer free. With MyBreathPrint, the hope is to achieve earlier noninvasive disease detection that could lead to less aggressive treatments and improved patient outcomes.”

Sign up for More Information